GDRX GoodRx
- 7.605
- -0.115-1.49%
GoodRx News
Subdued Growth No Barrier To GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Price
Wells Fargo Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Why Big Pharma Is Betting on Telehealth Strategies
Express News | GoodRx Holdings Shares Are Trading Higher Possibly After Eli Lilly Said Zepbound 2.5 Mg and 5 Mg Single-dose Vials Are Available for Self-pay for Patients With an On-label Prescription. GoodRx Offers Savings for Tirzepatide, the Generic Form of...
GoodRx to Participate in Upcoming Investor Conferences
RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
GoodRx Holdings Chief Accounting Officer Romin Nabiey Sells 55% Of Holding
RBC Capital Keeps Their Buy Rating on GoodRx Holdings (GDRX)
Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc ...
GoodRx Holdings: A Hold Rating Amid Mixed Performance and Market Challenges
Analysts Conflicted on These Healthcare Names: GoodRx Holdings (GDRX), NewAmsterdam Pharma Company (NAMS) and UniQure (QURE)
Express News | Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $10
GoodRx Holdings Is Maintained at Neutral by UBS
GoodRx Holdings Analyst Ratings
Express News | GoodRx Holdings Inc : UBS Cuts Target Price to $8.5 From $9
GoodRx Holdings (GDRX) Gets a Buy From TD Cowen
Truist Financial Keeps Their Hold Rating on GoodRx Holdings (GDRX)
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), GoodRx Holdings (GDRX) and Tenaya Therapeutics (TNYA)
GoodRx Holdings: Hold Rating Amidst Operational Strengths and Market Uncertainties
Raymond James Upgrades GoodRx Holdings to Strong Buy From Outperform
Analysis
Price Target
No Data
No Data